Multimodal AI prediction of head and neck cancer treatment outcomes with whole slide imaging.
Abstract
e18000 Background: Current risk stratification and adjuvant treatment decisions for head and neck cancer following surgical resection rely primarily on pathological risk factors. The growing adoption of digital pathology presents an opportunity to leverage histopathological image features to enhance risk stratification accuracy. This study investigated the performance of machine learning models for treatment outcome prediction using image features and traditional clinical variables, and identified optimal strategies for combining these modalities. Methods: We analyzed data from 645 patients in the publicly available HANCOCK dataset for model development and testing. All patients had head and neck cancers treated with primary surgery with or without adjuvant therapy. For each patient, H&E-stained whole slide images of the primary tumor and nine clinical variables served as model inputs. Slide-level image embeddings were extracted using a pretrained vision-language pathology foundation model (TITAN). Clinical variables included tumor site, pT classification, pN classification, histologic grade, perineural invasion, lymphovascular invasion, extranodal extension, margin status, and smoking history. Models were trained to predict survival, with performance measured by Harrell's concordance index (C-index), using an machine learning-based Cox proportional hazards model (DeepSurv). We compared unimodal models (using either clinical variables or image features alone) with multimodal models utilizing different fusion strategies (concatenation, late fusion, and cross-attention). Five-fold cross-validation with early stopping was implemented during training. Results: Unimodal models achieved C-indices of 0.62 +/- 0.04 (clinical variables) and 0.65 +/- 0.07 (image features). Multimodal models demonstrated progressive improvement: late fusion (0.63 +/- 0.05), concatenation (0.67 +/- 0.07), and cross-attention (0.69 +/- 0.07), with cross-attention achieving the highest performance. Conclusions: H&E-stained whole slide images from resected head and neck cancers contain significant prognostic information. Multimodal AI models integrating histopathological images with clinical variables, particularly using cross-attention fusion, enhance prognostic prediction and may improve risk stratification for adjuvant therapy decisions. Harrell's concordance index for each type of model input and feature fusion methods. Model input C-index (mean +/- std) Clinical variables alone 0.62 +/- 0.04 Image features alone 0.65 +/- 0.07 Multimodal (late fusion) 0.63 +/- 0.05 Multimodal (concatenation) 0.67 +/- 0.07 Multimodal (cross attention) 0.69 +/- 0.07
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (18)
Jiaxiang Sun
The Ohio State University, Columbus, OH
Yusuf Sadek
The Ohio State University, Columbus, OH
Yiming Zhu
Shanghai Key Laboratory for R&D and Application of Metallic Functional Materials, Institute of New Energy for Vehicles, School of Materials Science and Engineering
Sujith Baliga
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Emile Gogineni
The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH
John C. Grecula
The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH
David Joseph Konieczkowski
The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH
Darrion L. Mitchell
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Marcelo Raul Bonomi
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Priyanka Bhateja
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Mateus Trinconi Cunha
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
James William Rocco
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Arnab Chakravarti
James Cancer Hospital and Solove Research Institute, Columbus, OH
Dukagjin Blakaj
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Abberly Lott Limbach
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
Khalid Niazi
Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
Sung Jun Ma
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Simeng Zhu